European society of intensive care medicine study of therapeutic hypothermia (32-35°C) for intracranial pressure reduction after traumatic brain injury (the Eurotherm3235Trial)
2011

Eurotherm3235Trial: Study of Therapeutic Hypothermia for Traumatic Brain Injury

Sample size: 1800 publication Evidence: moderate

Author Information

Author(s): Peter JD Andrews, Helen Louise Sinclair, Claire G Battison, Kees H Polderman, Giuseppe Citerio, Luciana Mascia, Bridget A Harris, Gordon D Murray, Nino Stocchetti, David K Menon, Haleema Shakur, Daniel De Backer

Primary Institution: University of Edinburgh

Hypothesis

Patients treated with therapeutic hypothermia (32-35°C) have reduced morbidity and mortality rates compared to those receiving standard care alone after TBI.

Conclusion

The Eurotherm3235Trial aims to determine if therapeutic hypothermia can improve outcomes for patients with traumatic brain injury.

Supporting Evidence

  • Traumatic brain injury leads to 1,000,000 hospital admissions per year in the EU.
  • Therapeutic hypothermia has shown promise in improving outcomes after cardiac arrest.
  • Previous studies indicate that hypothermia lasting at least 48 hours may reduce mortality.

Takeaway

This study is trying to find out if cooling patients down helps them recover better after a serious head injury.

Methodology

This is a multi-centre randomised controlled trial examining the effects of hypothermia on morbidity and mortality after traumatic brain injury.

Potential Biases

Inter-centre variance in treatment effects and experience with hypothermia may introduce bias.

Limitations

The study may face challenges in recruitment and variability in treatment protocols across different centres.

Participant Demographics

Patients aged 18-65 with primary closed traumatic brain injury and raised intracranial pressure.

Digital Object Identifier (DOI)

10.1186/1745-6215-12-8

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication